Commit To Buy Synageva BioPharma Corp At $60, Earn 12.2% Annualized Using Options
July 11, 2014 at 12:16 PM EDT
Investors eyeing a purchase of Synageva BioPharma Corp (GEVA) stock, but cautious about paying the going market price of $79.02/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the January 2015 put at the $60 strike, which has a bid at the time of this writing of $3.80..